MAGE-3 (97-105)

MAGE-3 (97-105) is a synthetic peptide corresponding to amino acids 97 through 105 of the melanoma-associated antigen 3 (MAGE-3) protein, a member of the cancer-testis antigen family. Structurally defined by its short amino acid sequence, this peptide is recognized for its immunological relevance and its utility in antigen presentation studies. Its sequence is derived from a region of MAGE-3 known to be presented by major histocompatibility complex (MHC) class I molecules, making it highly significant for research into cellular immune responses, tumor immunology, and epitope mapping. As such, MAGE-3 (97-105) serves as a valuable research tool for the investigation of peptide-MHC interactions and the functional characterization of T cell recognition in the context of cancer and immunotherapy research.

Epitope Mapping: MAGE-3 (97-105) is widely utilized in the mapping of cytotoxic T lymphocyte (CTL) epitopes, particularly those presented by HLA-A*0201. Researchers employ this peptide to define the minimal sequence required for T cell receptor engagement and to delineate antigenic determinants recognized by tumor-infiltrating lymphocytes. Such studies are essential for understanding the specificity of immune responses against tumor-associated antigens and for identifying immunodominant epitopes that could be leveraged in the design of targeted immunotherapies or vaccines.

Antigen Presentation Studies: The peptide is instrumental in investigations of antigen processing and presentation pathways. By pulsing antigen-presenting cells with MAGE-3 (97-105), scientists can analyze the efficiency of peptide loading onto MHC class I molecules and the subsequent activation of antigen-specific CD8+ T cells. These experiments provide critical insights into the mechanisms governing immune surveillance and the factors influencing the presentation of tumor-associated epitopes, thereby supporting the rational design of immunomodulatory strategies.

Immunogenicity Assessment: Researchers frequently use this peptide in assays to evaluate T cell immunogenicity in vitro. By stimulating peripheral blood mononuclear cells or T cell lines with MAGE-3 (97-105), it is possible to assess the frequency, functional avidity, and cytokine production profile of antigen-specific T cells. Such analyses are pivotal for characterizing immune responses in cancer patients or healthy donors and for monitoring the efficacy of immunotherapeutic approaches targeting MAGE-3-expressing malignancies.

Peptide-Based Assay Development: The defined sequence and immunological relevance of MAGE-3 (97-105) make it a preferred standard in the development and validation of peptide-based assays, including ELISPOT, intracellular cytokine staining, and tetramer staining protocols. These assays enable the quantitative and qualitative measurement of antigen-specific T cell responses, supporting both basic research and translational studies focused on cellular immunity and biomarker discovery.

Peptide Synthesis and Structural Studies: MAGE-3 (97-105) serves as a model peptide for studies exploring peptide synthesis optimization and structure-activity relationships. Its defined sequence offers a useful template for examining peptide stability, solubility, and binding interactions with MHC molecules or T cell receptors. Such investigations facilitate the development of improved peptide analogs and contribute to the broader understanding of peptide-protein interactions relevant to immunological recognition and therapeutic peptide design.

1. Quantitative Analysis of Ligands Effects on Bioefficacy of Nanoemulsion encapsulating Depigmenting Active

2. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs

3. Uncarboxylated osteocalcin decreases insulin-stimulated glucose uptake without affecting insulin signaling and regulators of mitochondrial biogenesis in myotubes

4. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum

5. Odorant binding protein based biomimetic sensors for detection of alcohols associated with Salmonella contamination in packaged beef